Hiroyuki Watanabe

46PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsBiomedical imagingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jul 14, 2026
Improving Pharmacokinetics of PSMA/GRPR-Targeting Radiolabeled Heterodimer through Enhanced Albumin Binding.

|Jun 30, 2026
Bithiophene Scaffold for PET Imaging and Photosensitization as a Novel Theranostic Platform Targeting Amyloid-β Aggregates.

|Jun 23, 2026
Systematic Investigation of Fatty Acids with Different Carbon-Chain Length as Albumin Binder to Improve Tumor Accumulation of Radioligands.

|Jun 18, 2026
Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic Peptide.

|Jun 12, 2026
Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111In/177Lu Theranostics.

|Mar 24, 2026
Influence of the Binding Valency of Anti-HER2 Biparatopic Antibodies on Biodistribution in an SK-OV-3 Tumor Xenograft Model.

Hiroki Akiba, Kazuma Nakashima, Takayoshi Ichinose

Pageof 8

Frequent Collaborators

44 joint publications

Masahiro Ono

16 joint publications

Kazuma Nakashima

12 joint publications

Shimpei Iikuni

4 joint publications

Kosuke Saito